Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea
Lasers in Surgery and Medicine · 2026
DOI: 10.1002/lsm.70109 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lasers in Surgery and Medicine, 2026. Verfasst von Minsu Kim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea. Hauptthemen laut MEDLINE: Rosacea, Lasers, Dye, Doxycycline, Calcineurin Inhibitors. Die Arbeit nennt 46 Literaturangaben.
Abstract (Originalsprache)
Objective
Given that the therapeutic evidence for doxycycline in rosacea has predominantly been derived from studies on papulopustular rosacea (PPR), this study aimed to evaluate the efficacy and safety of combined oral doxycycline, topical calcineurin inhibitor (TCI), and pulsed dye laser (PDL) therapy in erythematotelangiectatic rosacea (ETR) and to identify clinical predictors of treatment response. Materials and Methods Medical photographs of patients with ETR treated with oral doxycycline, TCI, and two subsequent PDL sessions were retrospectively reviewed. Erythema on the right cheek was quantitatively measured using computer‐aided image analysis.
Results
Of the 79 included patients, 47 had the ETR subtype and 32 had the mixed ETR/PPR subtype. Erythema significantly improved after oral doxycycline and TCI treatment ( p < 0.001) and further PDL treatment ( p < 0.001). Particularly, in patients with moderate‐to‐severe ETR, background erythema improved to a level comparable to that observed in patients with mild ETR after treatment ( p = 0.307). Post‐treatment erythema did not differ by age ( p = 0.963) or Fitzpatrick skin type ( p = 0.277); however, it was significantly lower among males ( p = 0.008) and in patients without prior steroid treatment ( p = 0.046). No serious adverse events, including photosensitivity, were observed.
Conclusion
Combined oral doxycycline, TCI, and PDL therapy is effective and safe for ETR, especially in patients with higher severity. Prompt diagnosis and avoidance of steroid misuse may improve treatment responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea.
ORCID-Profile: Minsu Kim, Bo Ri Kim, Chong Won Choi, Sang Woong Youn
Zitieren
APA
Kim, M., Kim, B. R., Choi, C. W., & Youn, S. W. (2026). Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea. Lasers in Surgery and Medicine. https://doi.org/10.1002/lsm.70109
Vancouver
Kim M, Kim BR, Choi CW, Youn SW. Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea. Lasers in Surgery and Medicine. 2026. doi:10.1002/lsm.70109
BibTeX
@article{Kim2026,
author = {Kim, Minsu and Kim, Bo Ri and Choi, Chong Won and Youn, Sang Woong},
title = {Clinical Outcomes and Predictive Factors of Combination Treatment With Oral Doxycycline, Topical Calcineurin Inhibitor, and Pulsed Dye Laser in Erythematotelangiectatic Rosacea},
journal = {Lasers in Surgery and Medicine},
year = {2026},
doi = {10.1002/lsm.70109}
}
EUVIMED